Online TRT Therapy in 2026: How Telehealth Testosterone Replacement Actually Works

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Online TRT platforms require bloodwork before prescribing, typically including total testosterone, free testosterone, LH, FSH, and metabolic panels
• Legitimate telehealth TRT costs $99 to $299 monthly including medication, compared to $300 to $600 monthly through traditional clinics
• Federal law requires a provider-patient relationship established through video or phone consultation before any testosterone prescription
• Compounded testosterone from 503A pharmacies is legal and common in telehealth TRT, distinct from FDA-approved brand products

Direct answer (40-60 words)

Online TRT therapy connects patients with licensed providers through telehealth platforms for testosterone replacement treatment. After required bloodwork confirms low testosterone (typically under 300 ng/dL), a provider conducts a video consultation and writes a prescription sent to a partner pharmacy. Monthly costs range from $99 to $299 including medication and follow-up labs.

Table of contents

1. How online TRT platforms actually work (the 6-step process)
2. What most articles get wrong about telehealth testosterone legality
3. Required labs before any legitimate platform prescribes
4. Real pricing breakdown: 8 major platforms compared
5. Compounded vs. brand-name testosterone in telehealth
6. The three prescription pathways (and which platforms use which)
7. State-by-state restrictions on telehealth TRT
8. When online TRT makes sense vs. traditional urology
9. The FormBlends TRT evaluation framework
10. Follow-up protocol: what monitoring actually looks like
11. Insurance vs. cash pay for online TRT
12. FAQ

How online TRT platforms actually work (the 6-step process)

Online TRT isn't a shortcut around medical oversight. It's a different delivery model for the same clinical process that happens in a urologist's office.

Step 1: Initial intake questionnaire. You complete a medical history form covering symptoms (fatigue, low libido, erectile dysfunction, muscle loss), prior testosterone use, cardiovascular history, prostate health, and current medications. This takes 10 to 20 minutes.

Step 2: Baseline bloodwork order. The platform orders lab testing through Quest, LabCorp, or a partner network. You visit a local lab (usually within 5 miles of your address). No appointment needed at most Quest/LabCorp locations.

Standard panel includes:

• Total testosterone (measured in ng/dL)
• Free testosterone (calculated or measured directly)
• Luteinizing hormone (LH)
• Follicle-stimulating hormone (FSH)
• Estradiol (E2)
• Complete blood count (CBC)
• Comprehensive metabolic panel (CMP)
• Prostate-specific antigen (PSA) for men over 40

Step 3: Provider review and consultation. A licensed physician or nurse practitioner reviews your labs. If total testosterone is below the treatment threshold (most platforms use 300 to 350 ng/dL) and you have symptoms, the provider schedules a video or phone consultation.

This consultation is federally required. The Ryan Haight Act (2008) prohibits prescribing controlled substances without a provider-patient relationship established through real-time interaction (Leavitt, 2008). Testosterone is Schedule III.

Step 4: Prescription and treatment plan. If approved, the provider writes a prescription specifying:

• Testosterone formulation (cypionate, enanthate, or proprietary blend)
• Dose (typically 100 to 200 mg per week, divided into 1-2 injections)
• Injection frequency
• Ancillary medications if needed (anastrozole for estrogen management, HCG for fertility preservation)

Step 5: Medication delivery. The prescription goes to the platform's partner pharmacy (usually a 503A compounding pharmacy or a traditional retail pharmacy). Medication ships to your address within 3 to 7 days. Most platforms include syringes, alcohol wipes, and injection instructions.

Step 6: Ongoing monitoring. Follow-up labs occur at 6 weeks, 3 months, then every 6 months. The provider adjusts dosing based on symptom response and lab values. Most platforms include unlimited messaging with your provider between scheduled check-ins.

This process mirrors in-office TRT with two differences: the consultation happens via video instead of in-person, and medication usually comes from a compounding pharmacy instead of a retail chain filling a brand-name prescription.

What most articles get wrong about telehealth testosterone legality

The most common error in online TRT content is the claim that "telehealth TRT operates in a legal gray area." This is false.

Telehealth testosterone prescribing is explicitly legal under the Ryan Haight Act as amended by COVID-era DEA guidance and made permanent through the Consolidated Appropriations Act, 2023 (DEA, 2023). The law requires:

1. A provider-patient relationship established through real-time audio-visual or audio-only telemedicine
2. The provider holds an active DEA registration
3. The provider is licensed in the state where the patient is physically located during the consultation
4. The prescription is issued for a legitimate medical purpose

What creates confusion is the difference between prescribing testosterone (legal via telehealth) and prescribing certain other controlled substances (restricted). Testosterone is Schedule III. Buprenorphine for opioid use disorder, also Schedule III, has separate carve-out rules. Stimulants (Schedule II) have stricter requirements.

The second common error: "Compounded testosterone is illegal or unregulated." Compounded testosterone from a state-licensed 503A pharmacy is legal when prescribed for an individual patient. It's not FDA-approved, which is different from illegal. The FDA regulates compounding pharmacies under the Drug Quality and Security Act (2013), and state boards of pharmacy enforce compliance (FDA, 2022).

The third error: conflating telehealth TRT platforms with illegal "testosterone mills." Illegal operations skip the consultation, don't require labs, or prescribe to anyone who pays. Legitimate platforms follow the same standard of care as brick-and-mortar clinics.

If a platform doesn't require bloodwork before prescribing, doesn't conduct a live consultation, or guarantees approval regardless of labs, it's operating illegally. Those platforms exist, but they're not representative of the telehealth TRT category.

Required labs before any legitimate platform prescribes

No legitimate online TRT platform prescribes testosterone without baseline labs. The standard panel has expanded over the past decade as evidence on cardiovascular and metabolic risks has accumulated.

Testosterone measurements (required):

• Total testosterone: The primary diagnostic marker. Clinical hypogonadism is typically defined as total T below 300 ng/dL on two separate morning measurements (Bhasin et al., 2018). Most telehealth platforms use a single measurement if it's clearly low (under 250 ng/dL) and symptoms are present.
• Free testosterone: Calculated using total T, SHBG, and albumin, or measured directly. Free T represents bioavailable testosterone not bound to sex hormone-binding globulin. Some men have low-normal total T but low free T due to high SHBG.

Pituitary function (required):

• LH and FSH: Distinguish primary hypogonadism (testicular failure, high LH/FSH) from secondary hypogonadism (pituitary or hypothalamic dysfunction, low or normal LH/FSH). This matters because secondary hypogonadism sometimes responds to alternative treatments like clomiphene.

Estrogen and metabolic markers (required):

• Estradiol (E2): Baseline estrogen level. Testosterone aromatizes to estradiol, and some men develop elevated E2 on TRT, causing gynecomastia or mood changes.
• CBC: Checks for pre-existing polycythemia (elevated red blood cells). TRT increases hematocrit, and starting TRT in someone with borderline-high hematocrit increases thrombotic risk (Glueck et al., 2019).
• CMP: Liver and kidney function. Testosterone is metabolized hepatically, and chronic kidney disease affects dosing.

Prostate screening (required for men over 40):

• PSA (prostate-specific antigen): Baseline PSA before starting TRT. Elevated PSA (above 4.0 ng/mL, or above 2.5 ng/mL with rapid rise) requires urology referral before TRT initiation. TRT doesn't cause prostate cancer, but it can accelerate growth of existing cancer (Khera et al., 2016).

Optional but common add-ons:

• SHBG: Helps calculate free testosterone more accurately.
• DHEA-S: Adrenal androgen production, sometimes low in secondary hypogonadism.
• Thyroid panel (TSH, Free T4): Hypothyroidism mimics low-T symptoms.
• Vitamin D: Deficiency correlates with low testosterone and is easily corrected.
• Lipid panel: Baseline cholesterol before TRT, which can affect HDL.

Platforms that skip LH/FSH, estradiol, or CBC are cutting corners. Those three panels, plus total and free testosterone, represent the minimum standard of care.

Real pricing breakdown: 8 major platforms compared

Telehealth TRT pricing has three components: initial consultation and labs, monthly medication cost, and follow-up labs. Most platforms bundle these into a single monthly subscription.

Platform type	Initial cost	Monthly cost	What's included	What's extra
Subscription telehealth (typical)	$99 to $199 (consult + initial labs)	$99 to $199	Medication, syringes, provider messaging, dosing adjustments	Follow-up labs ($75-150 every 6 months)
Pay-per-visit telehealth	$150 to $250 (consult only, labs separate)	$40 to $80 (medication only)	Medication	Labs ($200-350 per panel), follow-up visits ($75-150 each)
Compounding-focused platforms	$129 to $249	$129 to $249	Compounded testosterone, all supplies, unlimited provider access	Follow-up labs (sometimes included, sometimes $100-150)
Traditional urology (for comparison)	$200 to $400 (office visit + labs through insurance)	$30 to $150 (insurance copay for brand Rx)	Office visit, prescription	Labs if insurance doesn't cover, prior authorization delays
Men's health clinics (cash)	$300 to $600	$300 to $600	Medication, labs, in-person visits	None (all-inclusive)
DIY underground (illegal)	$0 (no medical oversight)	$40 to $100	Testosterone only, no ancillaries	Everything else, plus legal risk and health risk

The subscription telehealth model ($99 to $199/month all-in) undercuts traditional men's health clinics by 50% to 70% while maintaining the same clinical oversight. The cost advantage comes from:

1. No physical clinic overhead
2. Compounded testosterone ($30 to $60 per month wholesale) vs. brand-name ($150 to $300 retail)
3. Asynchronous provider communication (messaging vs. scheduled office visits)
4. Lab partnerships with Quest/LabCorp at negotiated rates

For a patient paying cash, telehealth TRT costs roughly the same as a gym membership. For a patient with insurance using a traditional urologist, the comparison depends on the insurance copay structure. If your copay for testosterone cypionate is under $50 and labs are covered, traditional urology may cost less. If you're paying full retail or fighting prior authorizations, telehealth wins.

Compounded vs. brand-name testosterone in telehealth

Most online TRT platforms prescribe compounded testosterone cypionate or enanthate from 503A compounding pharmacies. Some partner with retail pharmacies and prescribe brand-name products.

Compounded testosterone:

• Prepared by a state-licensed compounding pharmacy in response to an individual prescription
• Not FDA-approved (compounded drugs are exempt from the FDA approval process)
• Typically costs $30 to $80 per 10 mL vial (5 to 10 weeks of treatment depending on dose)
• Drawn from a vial using a syringe, same as brand-name injectable testosterone
• Concentration varies (common concentrations: 100 mg/mL, 200 mg/mL, or proprietary blends)

Brand-name testosterone:

• FDA-approved products: testosterone cypionate (Depo-Testosterone), testosterone enanthate (Xyosted auto-injector), testosterone undecanoate (Aveed, long-acting injection)
• Costs $150 to $400 per vial or injection without insurance
• Covered by most insurance plans with prior authorization
• Identical active ingredient (testosterone cypionate or enanthate) to compounded versions

The clinical difference is minimal. Both deliver bioidentical testosterone. The FDA-approval difference matters for regulatory and insurance purposes, not for pharmacology. A 200 mg injection of compounded testosterone cypionate produces the same serum testosterone curve as 200 mg of Depo-Testosterone (Diem et al., 2017).

Why do telehealth platforms prefer compounded testosterone?

1. Cost. Compounded testosterone allows the platform to offer all-inclusive pricing without insurance. Brand-name testosterone requires the patient to use insurance or pay $200+ per month out of pocket.
2. Flexibility. Compounding pharmacies can prepare custom concentrations and blends (for example, testosterone with HCG in one vial). Brand products come in fixed doses.
3. No prior authorization. Insurance-based brand prescriptions often require PA, which delays treatment by 1 to 3 weeks. Compounded prescriptions ship immediately.

When does brand-name make more sense?

• Your insurance covers testosterone with a low copay (under $50/month)
• You strongly prefer FDA-approved medications
• You want the Xyosted auto-injector (easier than drawing from a vial)

The choice is patient-specific. Both are legitimate medical options.

The three prescription pathways (and which platforms use which)

Online TRT platforms use one of three prescription models, each with different legal and logistical structures.

Pathway 1: Direct provider employment. The platform employs physicians and nurse practitioners as W-2 employees or 1099 contractors. The employed provider reviews your case, conducts the consultation, and writes the prescription under their own DEA number. The prescription goes to the platform's partner pharmacy.

This is the most common model. The platform controls the entire patient experience. The provider works exclusively (or primarily) for the platform.

Pathway 2: Provider network partnership. The platform partners with an independent physician group or telemedicine staffing company. You're matched with a provider from the network. That provider writes the prescription under their DEA number. The platform handles intake, labs, and pharmacy fulfillment, but the clinical decision is made by the external provider.

This model is common among platforms that operate in many states, because credentialing providers in 50 states is expensive. The partner network already has multi-state licensed providers.

Pathway 3: Prescription transfer from your existing provider. Some platforms don't prescribe testosterone themselves. Instead, they fulfill prescriptions written by your existing urologist or primary care provider. You bring a prescription, the platform fills it through their compounding pharmacy at a lower cost than retail.

This is the least common model but growing. It works for patients who already have a TRT prescription but want cheaper medication.

The clinical outcome is similar across all three pathways. The difference is who holds the liability (the platform's employed provider, the partner network, or your independent provider) and how the patient experience is structured.

FormBlends uses Pathway 1 for GLP-1 medications and would use the same model for testosterone if we expanded into that category. Direct employment gives us the most control over clinical quality and patient communication.

State-by-state restrictions on telehealth TRT

Telehealth TRT is legal in all 50 states, but some states impose additional requirements beyond federal law.

States with no additional restrictions (38 states): The provider must be licensed in the state where the patient is located during the consultation. The provider must hold an active DEA registration. Beyond that, standard telemedicine rules apply.

States with additional requirements (12 states):

• Texas: Requires an in-person visit before prescribing controlled substances via telemedicine, with exceptions for established patients and certain rural areas. Most Texas-based platforms require an initial in-person visit at a partner clinic, then switch to telehealth for follow-up (Texas Medical Board, 2023).

• Arkansas: Requires the provider to conduct a physical exam before prescribing Schedule III controlled substances. This can be done via a partner clinic or a local provider who forwards exam notes to the telehealth provider.

• Louisiana: Requires an in-person exam within the past year before prescribing controlled substances via telemedicine.

• Missouri: Requires the provider to establish a "proper provider-patient relationship," which the state medical board interprets as requiring either an in-person visit or a video consultation with specific documentation.

• Idaho, South Dakota, West Virginia: Have similar in-person or enhanced-documentation requirements for controlled substance prescribing via telemedicine.

Most national telehealth TRT platforms handle these restrictions by partnering with local clinics in restricted states. You complete the initial visit in-person, then switch to telehealth for ongoing care. This adds $100 to $300 to the initial cost in those states.

States where telehealth TRT is effectively unavailable: None as of 2026. Even the most restrictive states allow telemedicine TRT with an initial in-person component.

Before signing up for a platform, confirm they operate in your state and understand any state-specific requirements. Most platforms display state availability on their homepage.

When online TRT makes sense vs. traditional urology

Online TRT isn't the right choice for every patient. The decision depends on your insurance situation, symptom complexity, and preference for in-person vs. remote care.

Online TRT makes sense when:

• You're paying cash and want predictable monthly costs ($99 to $199 vs. $300 to $600 at a men's health clinic)
• Your insurance doesn't cover TRT or requires burdensome prior authorizations
• You have straightforward primary hypogonadism (low T, low-normal LH/FSH, no complicating factors)
• You're comfortable with self-injection and remote provider communication
• You want faster access (most platforms go from signup to first injection in 2 to 3 weeks vs. 4 to 8 weeks through traditional urology)

Traditional urology makes sense when:

• Your insurance covers TRT with a low copay and you've already met your deductible
• You have secondary hypogonadism and want to explore fertility-preserving options (clomiphene, HCG monotherapy) before committing to TRT
• You have complicating factors: history of prostate cancer, severe polycythemia, uncontrolled sleep apnea, or heart failure
• You prefer in-person visits and physical exams
• You want access to all FDA-approved formulations, including gels (AndroGel, Testim), patches, and pellets (Testopel), which most telehealth platforms don't offer

The hybrid approach: Some patients use traditional urology for diagnosis and initial treatment planning, then switch to a telehealth platform for ongoing prescription fulfillment at lower cost. This works if your urologist is willing to transfer care (most are, if you're stable on treatment).

The clinical quality of care is comparable between good telehealth platforms and good urology practices. The difference is cost structure, convenience, and medication sourcing (compounded vs. brand).

The FormBlends TRT evaluation framework

We don't currently offer TRT at FormBlends, but if we did, we'd apply the same clinical rigor we use for GLP-1 therapy. Here's the framework we'd use, based on patterns we see in hormone replacement decision-making.

The Four-Gate Assessment Model:

Gate 1: Symptomatic hypogonadism confirmed. Not just low testosterone on a lab report. Symptoms must be present and attributable to low T, not to other causes. The symptom cluster includes persistent fatigue unrelieved by sleep, reduced libido, erectile dysfunction, loss of muscle mass, increased body fat, and mood changes (depression, irritability).

Many men have total testosterone in the 250 to 350 ng/dL range with zero symptoms. Those men don't need TRT. The lab threshold is a screening tool, not a diagnosis.

Gate 2: Reversible causes ruled out. Before starting lifelong TRT, address reversible causes of low testosterone:

• Obesity (weight loss increases T by 50 to 100 ng/dL per 10 kg lost in obese men) (Corona et al., 2013)
• Uncontrolled diabetes (glycemic control improves T)
• Opioid use (chronic opioid therapy suppresses the hypothalamic-pituitary axis)
• Sleep apnea (CPAP treatment increases morning T by 50 to 100 ng/dL) (Meston et al., 2003)
• Medications (glucocorticoids, ketoconazole, spironolactone)

If a 35-year-old man with a BMI of 38 and total T of 280 ng/dL loses 50 pounds, his testosterone often normalizes without TRT. Starting TRT before addressing obesity locks him into treatment he might not need.

Gate 3: Fertility intentions clarified. TRT suppresses spermatogenesis. Most men on TRT become azoospermic (zero sperm count) within 6 months. This is reversible in most cases after stopping TRT, but recovery takes 6 to 18 months, and some men don't fully recover (Liu et al., 2017).

If the patient wants to preserve fertility, the options are:

• Delay TRT until after completing family planning
• Use HCG alongside TRT to maintain testicular function (partially effective)
• Bank sperm before starting TRT

Many telehealth platforms don't adequately screen for fertility intentions. A 28-year-old starting TRT without this conversation is a clinical failure.

Gate 4: Cardiovascular risk stratified. The relationship between TRT and cardiovascular events is contested. Meta-analyses show conflicting results depending on study selection (Borst et al., 2014). The current consensus: TRT probably doesn't increase CV risk in healthy men, but it might in men with pre-existing heart disease.

Before prescribing, stratify CV risk:

• Low risk (age under 50, no CV history, normal lipids, non-smoker): TRT is safe.
• Moderate risk (age 50 to 65, hypertension or hyperlipidemia controlled on meds): TRT is probably safe with monitoring.
• High risk (history of MI, stroke, or heart failure): Refer to cardiology before starting TRT.

If all four gates are passed, TRT is appropriate. If any gate is failed, either address the underlying issue or choose an alternative.

[Diagram suggestion: Four-gate flowchart with yes/no decision points leading either to "Appropriate for TRT" or "Address X first" or "Consider alternative"]

Follow-up protocol: what monitoring actually looks like

TRT isn't a "prescribe and forget" medication. Ongoing monitoring is required to catch complications early.

Standard monitoring schedule:

Week 6 (first follow-up):

• Symptom check-in (energy, libido, mood)
• Labs: total testosterone (trough level, drawn the morning of your injection before you inject), estradiol, CBC
• Dose adjustment if needed (most patients need 1 to 2 adjustments in the first 6 months to dial in the right dose)

Month 3:

• Symptom check-in
• Labs: total and free testosterone, estradiol, CBC, CMP
• PSA if over 40

Month 6 and every 6 months thereafter:

• Full symptom review
• Labs: total and free testosterone, estradiol, CBC, CMP, lipid panel, PSA if over 40
• Dose adjustment if symptoms or labs indicate need

What providers are watching for:

Hematocrit elevation. TRT stimulates red blood cell production. Hematocrit (percentage of blood volume that's red blood cells) rises by 3% to 6% on average. If hematocrit exceeds 54%, thrombotic risk increases (Glueck et al., 2019). Management options: reduce dose, donate blood, or switch to a lower-dose more-frequent injection schedule (daily instead of weekly).

Estradiol elevation. Testosterone aromatizes to estradiol via the aromatase enzyme, especially in adipose tissue. Some men develop E2 levels above 40 to 50 pg/mL, causing gynecomastia (breast tissue growth), water retention, or emotional lability. Management: reduce dose, add an aromatase inhibitor (anastrozole 0.25 to 0.5 mg twice weekly), or increase injection frequency to smooth out peaks.

PSA rise. A PSA increase of more than 1.4 ng/mL in one year, or PSA above 4.0 ng/mL, requires urology referral and consideration of prostate biopsy (Khera et al., 2016). TRT is paused until prostate cancer is ruled out.

Symptom non-response. About 20% of men with confirmed low T don't experience symptom improvement on TRT (Snyder et al., 2016). This suggests the symptoms were not caused by low testosterone. In those cases, TRT is discontinued and alternative diagnoses are pursued (depression, sleep disorder, thyroid dysfunction).

Platforms that don't conduct 6-week follow-up labs are skipping a critical safety checkpoint. The first dose adjustment is the most important.

Insurance vs. cash pay for online TRT

Most online TRT platforms operate on a cash-pay model, but some accept insurance or offer insurance-billing options.

Cash-pay model (most common):

• You pay the platform's monthly fee ($99 to $299) out of pocket
• The platform handles everything: provider visit, labs, medication, shipping
• No insurance involvement, no prior authorization, no claims
• You can submit a superbill to your insurance for potential reimbursement (success rate varies)

Insurance-billing model (less common):

• The platform bills your insurance for the provider visit and labs
• You pay your normal copay or coinsurance
• The prescription is sent to a retail pharmacy where you use your insurance
• The platform charges a monthly platform fee ($20 to $50) on top of your insurance costs

Which is better?

For most patients, cash-pay is simpler and often cheaper. Here's why:

A typical insurance-based TRT journey costs:

• Specialist copay for initial visit: $40 to $75
• Lab copay (if not covered): $50 to $200
• Monthly prescription copay: $30 to $150
• Follow-up visit copays: $40 to $75 every 3 to 6 months
• Total annual cost: $800 to $2,200

A typical cash-pay telehealth TRT journey costs:

• Initial consult and labs: $150 to $250
• Monthly subscription: $99 to $199 x 12 = $1,188 to $2,388
• Follow-up labs: $100 to $150 x 2 = $200 to $300
• Total annual cost: $1,538 to $2,938

The cash-pay model costs more in year one if your insurance copays are low. But it saves time (no prior authorizations, no claim denials) and provides predictable monthly costs.

If your insurance covers TRT with a $30 copay and you've already met your deductible, use insurance through a traditional provider. If your copay is over $100, or if you're fighting prior authorizations, cash-pay telehealth is usually better.

One exception: HSA/FSA funds can be used for cash-pay telehealth TRT, which effectively makes it pre-tax spending.

FAQ

Is online TRT legal? Yes. Telehealth testosterone prescribing is legal under federal law (the Ryan Haight Act as amended) and legal in all 50 states. Some states require an initial in-person visit or additional documentation, but no state prohibits it entirely.

Do I need a prescription for online TRT? Yes. Testosterone is a Schedule III controlled substance. Any platform that sells testosterone without requiring a prescription from a licensed provider is operating illegally. Legitimate platforms require bloodwork, a medical history, and a live consultation before prescribing.

How much does online TRT cost per month? Typically $99 to $299 per month, all-inclusive (medication, provider access, supplies). Initial setup costs $100 to $250 for the first consultation and baseline labs. Follow-up labs cost $75 to $150 every 6 months.

What testosterone level qualifies for TRT? Most providers use a threshold of 300 ng/dL total testosterone, measured on two separate morning blood draws. Some use 264 ng/dL (the lower limit of the reference range). Symptoms must also be present. High-normal testosterone (400 to 600 ng/dL) with symptoms usually doesn't qualify.

Can I use insurance for online TRT? Some platforms bill insurance for the consultation and labs, but most operate on a cash-pay model. You can submit a superbill to your insurance for potential reimbursement, but coverage varies widely. Most patients find cash-pay telehealth simpler than navigating insurance.

Is compounded testosterone safe? Yes, when prepared by a licensed 503A compounding pharmacy. Compounded testosterone contains the same active ingredient (testosterone cypionate or enanthate) as FDA-approved brands. The difference is regulatory oversight (FDA for brands, state boards of pharmacy for compounders), not safety or efficacy.

How long does it take to start online TRT? Most platforms go from signup to first injection in 2 to 3 weeks. The timeline: intake (1 day), lab visit (1 to 3 days), lab results (1 to 3 days), provider consultation (1 to 5 days), medication shipping (3 to 7 days).

Do online TRT platforms prescribe HCG? Many do. HCG (human chorionic gonadotropin) is often prescribed alongside testosterone to maintain testicular size and preserve fertility. It's an additional cost, typically $50 to $100 per month. Not all patients need it.

What if my labs don't qualify for TRT? If your testosterone is above 300 to 350 ng/dL, most platforms won't prescribe TRT. Some offer alternative treatments (clomiphene, enclomiphene, lifestyle optimization programs). If you disagree with the decision, you can seek a second opinion from a traditional provider.

Can I switch from my current TRT provider to an online platform? Yes. If you're already on TRT through a urologist or men's health clinic, most online platforms will take over your care. You'll need recent labs (within 3 to 6 months) and your current prescription details. The platform's provider reviews your case and continues your treatment, often at lower cost.

Do I have to inject myself? Yes, for injectable TRT. Most online platforms prescribe testosterone cypionate or enanthate, which you inject into your thigh or glute muscle using a small needle (25G to 27G, 1 to 1.5 inches). The injection takes 30 seconds once you're comfortable with the process. Some platforms offer injection training videos.

What happens if I stop TRT? Your body's natural testosterone production restarts over 3 to 12 months in most cases. Younger men (under 40) recover faster. Some men don't fully recover, especially if they were on TRT for many years. Post-cycle therapy (HCG, clomiphene) can speed recovery.

Can women use online TRT platforms? Some platforms prescribe low-dose testosterone for women with androgen deficiency (usually post-menopausal women with low libido and fatigue). The dose is much lower than male TRT (5 to 10 mg per week vs. 100 to 200 mg). Not all platforms offer this.

Sources

1. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018.
2. Leavitt MO. 21 CFR Part 1301: Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Federal Register. 2008.
3. DEA. Telemedicine Prescribing of Controlled Substances: Permanent Rules. Drug Enforcement Administration. 2023.
4. FDA. Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration. 2022.
5. Glueck CJ et al. Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus. Clin Appl Thromb Hemost. 2019.
6. Khera M et al. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine. J Sex Med. 2016.
7. Diem SJ et al. Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med. 2017.
8. Texas Medical Board. Telemedicine Prescribing Standards. Texas Administrative Code. 2023.
9. Corona G et al. Weight loss and testosterone in obese men. Eur J Endocrinol. 2013.
10. Meston N et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med. 2003.
11. Liu PY et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception. J Clin Endocrinol Metab. 2017.
12. Borst SE et al. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration. Physiol Rep. 2014.
13. Snyder PJ et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016.
14. Drug Quality and Security Act. Public Law 113-54. U.S. Congress. 2013.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Depo-Testosterone, Xyosted, Aveed, AndroGel, Testim, and Testopel are registered trademarks of their respective manufacturers. Quest Diagnostics and LabCorp are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

Related FormBlends Guides

These related FormBlends guides cover nearby treatment, safety, and medication-comparison questions:

• Online Prescription for Testosterone in 2026: What's Legal, What's Safe, and What Actually Works
• Online Testosterone Therapy: A Clinical Guide to Telehealth TRT in 2026
• Can You Get TRT Online? What Actually Works in 2026